← Leaderboards
Ravindra N Singh
Univ Of Massachusetts Med Sch Worcester
$7,400,239
Attributed
$7,400,239
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $679.6K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,400,239 · 6
By mechanism
R01$5,640,595 · 1
R21$1,606,644 · 4
R03$153,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Maire F Osborn$164,204
- Jonathan K Watts$5,302,344
Others in their field
Top investigators on “Spinal Muscular Atrophy”
- Michael Watson · American College Of Medical Genetics$17,498,971
- Diane E Merry · Thomas Jefferson University$16,537,310
- Livio Pellizzoni · Columbia University Health Sciences$13,515,447
- Arthur H.m Burghes · Ohio State University$13,366,018
- Albert R La Spada · University Of Washington$13,268,603
- Charlotte Jane Sumner · Johns Hopkins University$12,001,647
Research focus
Spinal Muscular AtrophyRna SplicingExonsSmn2 GeneSurvival Motor Neuron GeneSiteMotor NeuronsMutationGenesIn VivoCell TypeBaseMouse ModelSmn1 GeneProteinsAntisense OligonucleotidesRegulatory ElementMediatingLengthCellsElementsComplexOligonucleotidesPathogenesis
Grant awards (30)
Transcriptome-Wide Effect of Therapeutic Antisense Oligonucleotides for the Treatment of Spinal Muscular Atrophy$76,500
R03 · FY2025 · NS · contact PI
Transcriptome-Wide Effect of Therapeutic Antisense Oligonucleotides for the Treatment of Spinal Muscular Atrophy$76,500
R03 · FY2024 · NS · contact PI
Splicing Regulation of Spinal Muscular Atrophy Genes$334,688
R01 · FY2023 · NS · contact PI
Splicing Regulation of Spinal Muscular Atrophy Genes$334,688
R01 · FY2022 · NS · contact PI
Splicing regulation of spinal muscular atrophy genes$334,688
R01 · FY2021 · NS · contact PI
Splicing regulation of spinal muscular atrophy genes$334,688
R01 · FY2020 · NS · contact PI
Splicing regulation of spinal muscular atrophy genes$22,900
R01 · FY2020 · NS · contact PI
Splicing regulation of spinal muscular atrophy genes$334,688
R01 · FY2019 · NS · contact PI
Characterization of a complex regulatory element of Spinal Muscular Atrophy genes$328,125
R01 · FY2018 · NS · contact PI
Dual-masking oligonucleotides as potential therapy of Spinal Muscular Atrophy$191,250
R21 · FY2018 · NS · contact PI
Characterization of a complex regulatory element of Spinal Muscular Atrophy genes$328,125
R01 · FY2017 · NS · contact PI
Dual-masking oligonucleotides as potential therapy of Spinal Muscular Atrophy$228,000
R21 · FY2017 · NS · contact PI
Characterization of a complex regulatory element of Spinal Muscular Atrophy genes$328,125
R01 · FY2016 · NS · contact PI
Characterization of a complex regulatory element of Spinal Muscular Atrophy genes$328,125
R01 · FY2015 · NS · contact PI
Characterization of a complex regulatory element of Spinal Muscular Atrophy genes$328,125
R01 · FY2014 · NS · contact PI
High-affinity RNA targets of Survival Motor Neuron Protein$209,301
R21 · FY2013 · NS · contact PI
Characterization of a complex regulatory element of Spinal Muscular Atrophy genes$316,877
R01 · FY2012 · NS · contact PI
Small Oligonucleotides As Therapeutic Agents Of Spinal Muscular Atrophy$182,607
R21 · FY2012 · NS · contact PI
High-affinity RNA targets of Survival Motor Neuron Protein$180,098
R21 · FY2012 · NS · contact PI
Characterization of a complex regulatory element of Spinal Muscular Atrophy genes$316,877
R01 · FY2011 · NS · contact PI
Small Oligonucleotides As Therapeutic Agents Of Spinal Muscular Atrophy$219,703
R21 · FY2011 · NS · contact PI
Characterization of a complex regulatory element of Spinal Muscular Atrophy genes$316,865
R01 · FY2010 · NS · contact PI
Characterization of a complex regulatory element of Spinal Muscular Atrophy genes$320,066
R01 · FY2009 · NS · contact PI
Characterization of a complex regulatory element of Spinal Muscular Atrophy genes$30,000
R01 · FY2009 · NS · contact PI
Characterization of a complex regulatory element of Spinal Muscular Atrophy genes$320,066
R01 · FY2008 · NS · contact PI
Characterization of a complex regulatory element of Spinal Muscular Atrophy genes$320,066
R01 · FY2007 · NS · contact PI
Targeting a novel silencer to correct SMN2 splicing in Spinal Muscular Atrophy$144,600
R21 · FY2007 · NS · contact PI
Targeting a novel silencer to correct SMN2 splicing in Spinal Muscular Atrophy$68,413
R21 · FY2007 · NS · contact PI
Characterization of a complex regulatory element of Spinal Muscular Atrophy genes$362,813
R01 · FY2006 · NS · contact PI
Targeting a novel silencer to correct SMN2 splicing in Spinal Muscular Atrophy$182,672
R21 · FY2006 · NS · contact PI